Rodino-Klapac Louise - Insider Non-Derivative Transactions at Sarepta Therapeutics, Inc. (SRPT) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 24, 2024, Rodino-Klapac Louise's relationship to Sarepta Therapeutics, Inc. (SRPT) is Officer (Head of R&D, CSO), and currently has 72,141 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SRPT insiders.

Data Source: SEC.
Rodino-Klapac Louise - Insider Non-Derivative Transactions of SRPT Common Stock
Rodino-Klapac Louise - Insider Non-Derivative Transactions at SRPT
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jun 25, 2024 F -- (Common Stock) 2182 164.64 72141
Jun 22, 2024 M -- (Common Stock) 6250 0 74323
Mar 9, 2024 F -- (Common Stock) 909 123.14 68073
Mar 8, 2024 F -- (Common Stock) 512 120.49 68982
Mar 5, 2024 F -- (Common Stock) 1728 125.32 69494
Mar 2, 2024 F -- (Common Stock) 778 126.19 65222
Mar 2, 2024 Acquisition -- (Common Stock) 6000 0 71222
Nov 18, 2023 F -- (Common Stock) 4508 82.98 65751
Mar 9, 2023 F -- (Common Stock) 912 153.19 70170
Mar 7, 2023 F -- (Common Stock) 1134 157.21 66582
Mar 7, 2023 Acquisition -- (Common Stock) 4500 0 71082
Mar 2, 2023 F -- (Common Stock) 522 147.57 67716